Skip to content
Review Open access

Application of type 2 inflammation-related biomarkers in risk prediction models for acute exacerbations in adult asthma: a systematic review

Sep 2026 · Frontiers in Medicine · Vol 13 · 0 citations · 43 references
Medicine

TL;DR

T2-related biomarkers may add complementary information to adult asthma exacerbation-risk models, but the available evidence does not yet establish BEC, FeNO, or IgE as independently sufficient predictors or support routine implementation of an existing model.

Abstract

Objective To systematically evaluate how type 2 (T2) inflammation-related biomarkers are incorporated into multivariable models that predict future acute exacerbations in adults with asthma, and to appraise model performance, validation, calibration, risk of bias, and clinical applicability. Methods PubMed, Embase, Web of Science, the Cochrane Library, and Scopus were searched from inception to May 2026, followed by a supplementary PubMed update through 31 July 2026. Eligible reports contained at least one adult cohort used to develop, validate, or update a longitudinal multivariable model for a future exacerbation outcome, incorporated at least one T2-related biomarker, and reported model performance or validation. Mixed-age cohorts were not counted as independent adult evidence; only performance evaluated in an adult cohort contributed to the main synthesis. Association-only studies, current-attack classification models, post-exacerbation disposition models, and post-index relapse models outside the prespecified baseline-risk setting were excluded. Data extraction followed CHARMS, and risk of bias and applicability were assessed using PROBAST. Results Eight reports published from 2021 to 2026 were included. Eligible adult cohorts ranged from 540 to 1,331,934 participants; one report also included a mixed-age randomized-trial comparator (n = 345). Modeling approaches included logistic and elastic-net regression, gradient-boosting and deep-learning algorithms, Bayesian networks, and a mixed-effects count model. Eosinophil-related variables appeared in all eight reports but were not retained in every final model; FeNO was included in two multinational severe-asthma registry models, and serum IgE appeared as a network node in one cross-source analysis and was retained in an independently replicated metabolomics model. The metabolomics model reported AUCs of 0.901 and 0.893 in discovery and replication cohorts, whereas an RCT-derived Bayesian network achieved an AUC of 0.68 when validated in the adult ISAR cohort. Six reports were rated at high overall risk of bias, mainly because of analysis-domain limitations. Conclusion T2-related biomarkers may add complementary information to adult asthma exacerbation-risk models, but the available evidence does not yet establish BEC, FeNO, or IgE as independently sufficient predictors or support routine implementation of an existing model. Future studies should quantify incremental biomarker value beyond established clinical predictors and prioritize adequate sample size, external validation, calibration, clinical utility, transparent handling of missing biomarker data, and reproducible model presentation. Systematic Review Registration https://www.crd.york.ac.uk/prospero/, PROSPERO CRD420261415469.

Read PDF

Similar papers

Review Open access Oct 2026

Inflammatory burden index predicts long-term mortality: evidence from population-based cohorts with clinical validation

Background Systemic inflammation is increasingly recognized as a key determinant of long-term health outcomes. The Inflammatory Burden Index (IBI), derived from C-reactive protein, neutrophil count, and lymphocyte count, integrates multiple components of systemic inflammatory and immune status. However, evidence regard...

Yu-Zheng Zhang, Xin-Yi Yu, Zhi-Fang Jia et al. · 0 citations
Review Open access Sep 2026

Accuracy of type 2 inflammatory biomarkers to diagnose asthma in adults and children: a meta-analysis of 30 studies with prospective validation in an adult primary care cohort.

In both the meta-analysis and the DIVE cohort, FeNO diagnostic accuracy declined within 2 weeks of inhaled corticosteroid exposure, and FeNO thresholds correctly classifyied rule-in decisions and rule-out decisions.

M. Roy, M. Gronnier, Laurence Désy et al. · 1 citation
Review Sep 2026

Prediction models for sarcopenia risk in type 2 diabetes mellitus: A systematic review and meta-analysis.

Existing prediction models for sarcopenia or low muscle mass in T2DM patients show promising discrimination, but limitations in analysis methods, reporting and external validation may affect their robustness and generalisability.

Wei-Jun Tang, Rui Luo, Yue Luo et al. · 0 citations
Review Sep 2026

Early cardiovascular vulnerability after acute exacerbation of COPD: a time-windowed systematic review and evidence map.

The practical contribution is not a single pooled risk estimate, but a clinically interpretable map showing when respiratory recovery should be treated as cardiopulmonary transition-of-care, most consistently during the first month.

Jun-Song Xu, Qing-Yong Chen, Bing-Chen Zhang et al. · 0 citations
Meta-analysis Open access Sep 2026

Prediction models for sepsis-associated acute kidney injury: a systematic review and meta-analysis

Objectives This study aims to systematically evaluate the predictive performance of risk models for sepsis-associated acute kidney injury (SA-AKI). Furthermore, we explore the specific factors that influence how effectively these models perform in clinical settings. Methods We systematically searched PubMed, The Cochra...

M. Huang, S. Wu, Zi-Han Shen et al. · 0 citations
Review Open access Sep 2026

Potential Biomarkers for the Early Prediction of Prediabetes

Background/Objective: Prediabetes is increasingly recognized as a state of chronic, low-grade inflammation that contributes to early β-cell dysfunction, insulin resistance, and progression to type 2 diabetes (T2D). This review synthesizes mechanistic and clinical evidence to characterize the inflammatory landscape of p...

Luisa V. Gracia Mazuca, Bibiana Mancera · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.